What should you know about DMARDs for psoriatic arthritis?

Disease-modifying antirheumatic drugs work on the inflammatory process behind psoriatic arthritis rather than only masking discomfort. Conventional medicines and targeted medicines may be considered, depending on which joints, skin areas, nails, or other tissues are affected. Improvement may take time, so early treatment response is assessed alongside pain, swelling, morning stiffness, movement, and skin symptoms.

DMARDs can have effects beyond the joints. Your clinician may review previous infections, vaccinations, liver or kidney problems, pregnancy plans, and other medicines before choosing an option. Blood tests or other checks can be part of safe follow-up.

Take the medicine exactly as prescribed and do not stop it suddenly without advice. Keep a simple record of swollen joints, morning stiffness, skin flares, and unwanted effects. Attend planned blood tests and tell the prescribing team about new medicines or supplements. Ask what to do after a missed dose and whether you should pause treatment during an infection.

Medication is often combined with movement advice and rehabilitation. Physiotherapy can support strength, joint protection, and function while inflammation is being treated.

Contact your treatment team promptly for fever, a persistent cough, painful urination, unusual bruising, yellowing of the skin, severe abdominal symptoms, or a marked change after starting or changing a DMARD. Seek urgent help for breathing difficulty, facial swelling, or a rapidly worsening illness. New or worsening joint pain, swelling, or morning stiffness also deserves review because the treatment plan may need adjustment.

Which DMARD fits my joint and skin symptoms? What monitoring will I need, and how will we judge whether it is working? Which vaccines, infections, or medicines should I discuss before treatment?